Suppliers · Producer · Discovered — similar established company

Abolis Biotechnologies

Abolis Biotechnologies is a French biotechnology company specializing in microbial systems and industrial-grade biotech applications for the food, cosmetics, healthcare and chemical industries. The company helps innovators, manufacturers and R&D teams understand complex microbial systems and address critical industrial challenges through ingredient and biotics development, process optimisation and …

active FranceEurope Founded 2014 UnlistedEmployees: 68 Revenue: 4.78 million EUR (2025) checked 2026-10-05

Profile

Industry: Cosmetics, Industrial chemistry
Topics: Synthetic biology platforms & biomanufacturing
Role: Producer — “…ment and potential contract manufacturing in biotech Note: The available content does not list specific produc…”
Why it is bioeconomy: Abolis Biotechnologies is a French company specializing in industrial-grade microbial systems and biotechnology applications for sectors including food, cosmetics, healthcare, and chemicals.
Found via: [Rubric] France · biosurfactants; [Rubric] France · food-ingredients; [Rubric] France · lipase-oils

Bio-solutions it supplies 0

Not yet cited as a supplier in a graded solution.

What they offer

This company does not publish its products or services — we find out through an introduction.

News & status 6

2026-06 Latest status: The company has undergone routine corporate filings and capital modifications since January 2024, including a partial asset contribution project in June 2026. ↗ ↗ ↗
2026-04-19 L’Oréal Groupe partners with Abolis and "Evonik" to scale development of next-generation bio-based ingredients
Abolis Biotechnologies is a French biotech company developing tailor-made, microbe-powered solutions for diverse industries (including cosmetics, healthcare, food, and chemistry), and it is expanding through a tri-party collaboration with L’Oréal and Evonik, …
2026-09-30 Abolis Biotechnologies’ new platform boosts discovery of microbial-derived cosmetic ingredients
Abolis Biotechnologies has launched the Microbial Intelligence Explorer (MINE), a platform that speeds discovery and industrial application of microbial-derived cosmetic ingredients by integrating genomic and multi-omics data with experimental insight, making …
2025-10-23 Abolis Biotechnologies and EUROAPI enter into partnership to accelerate pharmaceutical innovation and restore European sovereignty - Abolis Biotechnologies
Abolis Biotechnologies is a French industrial biotechnology company partnering with EUROAPI to develop European-made microbial bioprocesses for corticosteroid production, aiming to restore pharmaceutical sovereignty in Europe with IPCEI-supported funding and a …
2026-10-01 Abolis launches MINE platform to streamline microbial and fermentation R&D
Abolis Biotechnologies has launched the Microbial INtelligence Explorer (MINE), a platform that integrates genomic and multi-omics data with experimental insight to streamline microbial R&D, reduce trial-and-error, and accelerate strain selection and scale-up …
2026-10-01 Abolis Launches MINE Microbial Data | Nose and Note
Abolis Biotechnologies has launched the MINE platform (Microbial Intelligence Explorer), evolving its internal Microbiome Studio to enable external R&D and open innovation in microbial biotech, linking microbial data to industrial feasibility for fragrance …
2026-10-01 Abolis helps businesses mine microbial data for ingredient gold - Food and Drink Technology
Abolis Biotechnologies launches MINE, a microbial-intelligence platform that accelerates ingredient and bioproduct development by integrating genomic and multi-omics data to guide smarter experimental design, strain/parameter prioritization, and scale-up …

Network: owners, partners, peers

Ownership & investors 7

parent	Independent
investor	L'Oréal
investor	Evonik
investor	DeepTech & Climate Fonds
investor	Clay Capital
investor	ICOS Capital
investor	Liberset

Partners & deals 2

manufacturing partner	Services or platforms suitable …ng biology/bioprocesses) - Services or platforms suitable for development and potential contract manufacturing in biotech Note: The available content does not list specific product names or techni…
collaboration	Venture Capital …k Venture Capital, and DeepTech & Climate Fonds. In October 2025, Abolis entered a strategic partnership with EUROAPI to develop microbial strains for corticosteroid production under the Med4Cur…

Similar companies

Lesaffre · Ennolys by Lesaffre · 21st.BIO · enginzyme · woresan GmbH · Biose Industrie · Biopolis S.L. · Unibio

Identity & contacts

Contacts, people and legal identity are available to members.